Jeong Soo Park

Title: Innovations of Jeong Soo Park in Coagulation Factor VIII Antibody

Introduction

Jeong Soo Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies related to coagulation factors.

Latest Patents

Jeong Soo Park holds a patent for an "Anti-coagulation factor VIII antibody and use thereof." This invention pertains to an antibody that specifically binds to coagulation factor VIII or an antigen binding fragment thereof. The patent details an antibody that includes specific sequences of heavy chain CDR and light chain CDR. Additionally, it describes a column where the antibody or its antigen binding fragment is coupled to a stationary phase as a ligand for isolating or purifying recombinant coagulation factor VIII. Furthermore, the patent outlines a method for purifying recombinant coagulation factor VIII using this innovative approach.

Career Highlights

Jeong Soo Park is currently associated with Pangen Biotech Inc., where he continues to advance his research and development efforts. His work focuses on creating solutions that enhance the understanding and treatment of coagulation disorders.

Collaborations

He collaborates with esteemed colleagues such as Jaeseung Yoon and Kwanghee Baek, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jeong Soo Park's contributions to the field of biotechnology, particularly through his patent on anti-coagulation factor VIII antibodies, highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to impact therapeutic applications in medicine.